BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Nautilus Neurosciences, Inc.: New Analysis of CAMBIA(TM) Pivotal Data to be Presented at the 4th World Congress on Controversies in Neurology

  October 26, 2010

   · 

  4 min read
• Drug Development

  PTC Therapeutics, Inc. Initiates Phase 2 Clinical Trial of Ataluren in Patients With Methylmalonic Acidemia

  October 26, 2010

   · 

  5 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study

  October 26, 2010

   · 

  7 min read
• Business

  Strativa Pharmaceuticals Signs Agreement With Swedish Orphan Biovitrum Regarding Nascobal(R)

  October 26, 2010

   · 

  5 min read
• Policy

  Tenaxis Medical, Inc. Announces ‘Fileable’ Status of PMA

  October 26, 2010

   · 

  1 min read
• BioCapital

  Recall of Hyland’s Teething Tablets

  October 26, 2010

   · 

  1 min read
• Business

  Tengion Inc. to Host Conference Call to Provide a Business Update and Report Third Quarter 2010 Financial Results on November 1, 2010

  October 26, 2010

   · 

  1 min read
• Business

  Celgene Revises Expansion Plan In Summit

  October 26, 2010

   · 

  1 min read
• Business

  Resolvyx Pharmaceuticals, Inc. and Celtic Therapeutics Ink Dry Eye Deal

  October 26, 2010

   · 

  6 min read
• Business

  Infinity Pharmaceuticals Inc. Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Limited Exercise Rights to Develop and Commercialize Infinity’s FAAH Pain Program Worldwide

  October 26, 2010

   · 

  1 min read